Bioretec earns breakthrough designation for spinal interbody cage

Bioretec earned the FDA’s breakthrough device designation for its RemeOs spinal interbody cage, the company said March 14.

Advertisement

RemeOs is designed to restore intervertebral height and facilitate cervical spinal fusion, according to a news release. 

With breakthrough designation Bioretec will look into accelerating development of RemeOs.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.